Isoglycemic clamp

DRUG2 trials

Sponsors

Herlev Hospital, Merck Sharp & Dohme LLC

Conditions

DiabetesIncretin Effect

Phase 1

Pharmacodynamic and Pharmacokinetic Variability of a Basal Insulin (0000-168)

CompletedNCT01152242

Merck Sharp & Dohme LLCDiabetes

Start: 2010-08-31End: 2012-05-31Updated: 2015-07-23

Unknown Phase

Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes

CompletedNCT00529048

Herlev HospitalIncretin Effect

Start: 2007-10-31End: 2009-09-30Updated: 2009-10-20

Related Papers

Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes

Nutrients2020-09-245 citations

Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals.

2014-05-3151 citations